The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...

How can advancements in precision medicine and biomarker development improve treatment strategies for pulmonary fibrosis? How do you envision AI impacting management strategies of patients with IPF ...

Liver fibrosis is the buildup of scar tissue in the liver, the organ that helps you digest food, store energy, and remove toxins. Liver fibrosis occurs as the organ tries to repair itself from ...

Progressive pulmonary fibrosis (PPF) presents a significant challenge in respiratory medicine, characterized by disease progression despite conventional treatment, extending beyond idiopathic ...

A 47-year-old man with cystic fibrosis hopes that stories like his will be reassuring to younger people diagnosed with the illness. Advances in the standards of care, as well as the availability ...

of the Department of Pathology and Laboratory Medicine, University of California, San Francisco. Liver fibrosis is known to be the main driver of chronic liver disease as well as a key factor ...

Scientists found that oxalic acid can trigger the formation of gadolinium nanoparticles inside the body—particles linked to severe, sometimes deadly conditions like nephrogenic systemic fibrosis. The ...

States screen for cystic fibrosis (CF) but with significant variation among their screening algorithms. The Cystic Fibrosis Foundation group conducted a systematic review, leading to seven ...

The study, “Piezo2 Is a Key Mechanoreceptor in Lung Fibrosis that Drives Myofibroblast Differentiation,” was published in The American Journal of Pathology. In IPF, scar tissue buildup in the lungs ...

Objective: Although research on the association between pulmonary fibrosis and lung cancer is of great significance, to date, no bibliometric analysis has been conducted on the comorbidity of these ...